FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称EMAVUSERTIB
异名/同义词4-OXAZOLECARBOXAMIDE, N-(5-((3R)-3-HYDROXY-1-PYRROLIDINYL)-2-(4-MORPHOLINYL)OXAZOLO(4,5-B)PYRIDIN-6-YL)-2-(2-METHYL-4-PYRIDINYL)-
AU-4948
CA-4948
EMAVUSERTIB
EMAVUSERTIB [INN]
EMAVUSERTIB [USAN]
N-(5-((3R)-3-HYDROXYPYRROLIDIN-1-YL)-2-(MORPHOLIN-4-YL)(1,3)OXAZOLO(4,5-B)PYRIDIN-6-YL)-2-(2-METHYLPYRIDIN-4-YL)-1,3-OXAZOLE-4-CARBOXAMIDE
CAS登记号1801344-14-8
物质唯一标识(Unique Ingredient Identifier)MH5DMF9JKY
分子式C24H25N7O5
国际化合物标识(International Chemical Identifier,InChI)SJHNWSAWWOAWJH-MRXNPFEDSA-N
SMILESN(C(=O)c1nc(oc1)-c2cc(C)ncc2)c3c(nc4c(c3)oc(n4)N5CCOCC5)N6CC[C@@H](O)C6
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System